The 10 closest competitors and alternatives to Arc Therapeutics among drug discovery companies — ranked by similarity to what Arc Therapeutics actually does, not by market-cap band.
Subscribe to see Arc Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Arc Therapeutics partners with hospitals to establish specialty centers for the management and treatment of metastatic brain tumors. The company provides turnkey radiosurgical solutions, including the installation of Zap-X radiosurgical units, facility design, financial and operational support, clinical training, and multidisciplinary care coordination for cancer patients.
Arc Therapeutics is a drug discovery company headquartered in Singapore. Xcout tracks 3 named people at Arc Therapeutics, including H. Warren Goldman (Chief Medical Executive).
Ranked by semantic similarity — how close each company is to Arc Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Medtech
Artiria Medical is a medical technology company founded in 2019 and headquartered in Borex, Switzerland. The company develops cutting-edge technologies that empower catheters and guidewires to enable precise micromotion deep inside brain arteries.
Biopharmaceutical
Convergent Therapeutics, Inc. is a biotechnology research company based in Cambridge, Massachusetts, focused on developing next-generation targeted radiotherapies and combination therapies to treat cancer.
Biopharmaceuticals
ARMO BioSciences is a late-stage immuno-oncology company that develops a pipeline of novel, proprietary product candidates designed to activate the immune system of cancer patients to recognize and eradicate tumors.
Biopharmaceuticals
Fusion Pharmaceuticals is a pharmaceutical company focused on developing targeted radiopharmaceuticals for the treatment of cancer patients.
Biopharmaceuticals
AcelRx Pharmaceuticals, Inc., which has rebranded as Talphera, Inc., is a specialty pharmaceutical company focused on the development and commercialization of therapies and products for use in medically supervised settings.
Biopharmaceuticals
Carrick Therapeutics is a biopharmaceutical company with its corporate headquarters located in Boston, Massachusetts, focused on discovering and developing innovative cancer treatments.
Biopharmaceuticals
Citius Oncology is a biopharmaceutical company that develops and commercializes targeted oncology therapies. It serves patients with cancer, including its FDA-approved targeted immune therapy LYMPHIR for cutaneous T-cell lymphoma.
Shell Companies
ARC Group Acquisition I Corp. operates as a special purpose acquisition company (SPAC). Its primary objective is to execute a strategic business consolidation, which may involve a merger, share exchange, asset acquisition, corporate reorganization, or another similar transaction. The entity, headquartered in Tempe, Arizona, began its operations on May 27, 2025.
Radiopharmaceuticals
Alpha-9 Theranostics is a clinical-stage biotechnology and radiopharmaceutical company based in Canada. The company specializes in developing targeted, differentiated radiopharmaceuticals and precision-targeting molecules for cancer treatment and solid tumors.
Neuroscience
RAPT Ventures, Inc. develops home-based neuroscience products that utilize structured auditory experiences to enhance and maintain brain performance. The company leverages neuroplasticity to support cognitive functions and brain structure across all life stages, ranging from language processing foundations in infants to neural system maintenance in older adults.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Arc Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →